Skip to main navigation

Skip to Content

Overview
Stock Information
SEC Filings
Corporate Governance
Company
Contact Us
ImmunityBio.com

Event

Investor Live Audio Webcast - ANKTIVA Post Approval

Apr 26, 2024

IR Tools

© 2024 ImmunityBio, Inc. All Rights Reserved.

A member of the NantWorks ecosystem of companies

'Nantkwest’, ‘Conkwest’, ‘haNK’, ‘taNK’, ‘vaNK’, ’t-haNK’, ‘ceNK’, ‘NK-92’, ‘Neukosome’, ‘Living Drugs in a Bag’, ‘Nature’s First Responder’, ‘Infacell’, ‘Outsmart Your Disease’, and ‘Smart Therapies for Difficult Diseases’ are trademarks or registered trademarks of Nantkwest, Inc.

Anktiva is a trademark of ImmunityBio, Inc.

The Natural Killer Cell platform consists of investigational agents that are restricted by federal law to investigational use only.

The Natural Killer Cell platform is being investigated in multiple clinical trials across tumor sites.

The content of this website is protected by Title 17 of the U.S. Code and may not be reproduced in whole or in part by any means.

NantKwest

Visit ImmunityBio.com

Social icons